unknown
Stage
1
Investors
About
DynamoBio AG develops advanced biotechnological solutions that aim to more accurately model human biology for therapeutics development, moving beyond traditional animal-based systems to improve prediction of human disease and treatment outcomes.
Explore DynamoBio AG's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.